Results 21 to 30 of about 445,656 (308)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells

MedComm, 2023
Drug resistance remains the greatest challenge in improving outcomes for cancer patients who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a subpopulation of cancer cells could escape intense selective drug treatment by ...
Xiaohai Song, Yang Lan, Xiuli Zheng, Qianyu Zhu, Xuliang Liao, Kai Liu, Weihan Zhang, QiangBo Peng, Yunfeng Zhu, Linyong Zhao, Xiaolong Chen, Yang Shu, Kun Yang, Jiankun Hu   +13 more
doaj   +1 more source

A Comparative Study of Helicobacter pylori Growth on Different Agar-based Media

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2017
Background/Aims: Optimal culture conditions for Helicobacter pylori have not been established. We compared the effectiveness of four different agar-based media for the growth of H. pylori.
Jung Hwan Lee, Jiwan Park, Mi Ri Park, Yoon Hee Na, Soo-Jeong Cho   +4 more
doaj   +1 more source

Detection of secondary upper gastrointestinal tract cancer during follow‐up esophagogastroduodenoscopy after gastrectomy for gastric cancer

Annals of Gastroenterological Surgery, 2022
Aim Esophagogastroduodenoscopy (EGD) may contribute to early detection of secondary cancer in the upper gastrointestinal tract although the clinical relevance of follow‐up after gastrectomy remains unclear. This study aimed to elucidate the effectiveness
Kosuke Nakane, Keiichi Fujiya, Masanori Terashima, Takanori Kawabata, Yosuke Matsumoto, Satoshi Kamiya, Makoto Hikage, Yutaka Tanizawa, Hiroyuki Ono, Etsuro Bando   +9 more
doaj   +1 more source

Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center

BMC Cancer, 2018
Background Greater lymph node retrieval in gastric cancer improves staging accuracy and may improve survival from increased clearance of nodal micrometastasis.
Shiela S. Macalindong, Kwang Hee Kim, Byung-Ho Nam, Keun Won Ryu, Norihito Kubo, Ja Yeon Kim, Bang Wool Eom, Hong Man Yoon, Myeong-Cherl Kook, Il Ju Choi, Young Woo Kim   +10 more
doaj   +1 more source

The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma

Annals of Gastroenterological Surgery, 2022
Aim A hiatal hernia (HH) complicates the diagnosis and surgical treatment of gastroesophageal junction (GEJ) cancer. This study aimed to investigate the effect of HH on the survival outcomes of GEJ cancer patients.
Yuya Tanaka, Takahiro Kinoshita, Eigo Akimoto, Reo Sato, Masahiro Yura, Junichiro Harada, Mitsumasa Yoshida, Yoshiaki Tomi   +7 more
doaj   +1 more source

Recurrence after ESD curative resection for early gastric cancer

Surgical Case Reports, 2021
Background Endoscopic submucosal dissection (ESD) is gaining ground as a minimally invasive treatment for early gastric cancer (EGC) that has a negligible risk of lymph node metastasis.
Ayako Kamiya, Hitoshi Katai, Kenichi Ishizu, Takeyuki Wada, Tsutomu Hayashi, Sho Otsuki, Yukinori Yamagata, Takaki Yoshikawa, Shigeki Sekine, Tomohiko Nishi, Yuka Kawasaki, Takafumi Ito, Hideharu Domoto   +12 more
doaj   +1 more source

Gastric Cancer and Gastric Microbiome

The Korean Journal of Gastroenterology, 2023
Gastric cancer remains a significant disease burden in Korea, with Helicobacter pylori infections being the most crucial risk factor. With the advent of next-generation sequencing, the role of gastric microbiota in gastric cancer has attracted increasing attention.
openaire   +3 more sources

Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification

Gut and Liver, 2017
Background/AimsDelayed bleeding after gastric endoscopic submucosal dissection (ESD) commonly occurs within 3 days, but it may also occur after 1 week following ESD, especially in antiplatelet agent users.
Jong Yeul Lee, Chan Gyoo Kim, Soo-Jeong Cho, Young-Il Kim, Il Ju Choi   +4 more
doaj   +1 more source

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

BMC Gastroenterology, 2021
Background This randomized, open-label trial aimed to compare the efficacy of 10-day bismuth-containing quadruple therapy (BQT) with 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT) as an empirical first-line ...
Young-Il Kim, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Jin Young Park, Il Ju Choi   +5 more
doaj   +1 more source

Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patients

Cancer Medicine, 2023
Background Ovarian metastasis (OM) results in poor survival of gastric cancer (GC) patients. While immunotherapy has emerged as a promising approach for late‐stage GC, validated immune‐related prognostic signatures still remain in need. In this study, we
Jianpeng Gao, Shiying Huo, Yu Zhang, Zhenxiong Zhao, Hongda Pan, Xiaowen Liu   +5 more
doaj   +1 more source